Orthobond received on April 5th de novo approval for the company’s spinal fusion device with quaternary ammonium compound coating. Orthobond’s antibacterial treatment, Ostaguard™, covalently bonds its antimicrobial, polycationic molecules to the surface of an implant before packaging and sterilization….
By: Knobbe Martens
By: Knobbe Martens
